Latest filing published 25 Aug 2026 for Precigen, INC..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Phil Tennant discloses dealings in Precigen, Inc. to SEC (Form 4). Between 29 January 2025 and 25 August 2026, the trades on record add up to 10 filings.
Both buying and selling appear: 1 purchase worth €18k, against 1 sale worth €509k. Netting one side against the other leaves €491k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants and 4 option exercises. 2026 to date brings no purchases and 1 sale.
On 25 August 2026 came the latest disclosure, an option exercise in Precigen, Inc. The latest purchase dates back some time: it was published 389 days ago, on 30 September 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations